Home » Topics » BioWorld Science

BioWorld Science
RSS

Aminex initiates phase I study of AMXT-1501 dicaprate in advanced solid tumors

June 18, 2018

Celltrion resubmits aBLA for trastuzumab biosimilar CT-P6

June 18, 2018

Nirogacestat receives U.S. orphan drug designation for desmoid tumors

June 18, 2018

Stemline Therapeutics presents data on SL-401 potentially useful in systemic sclerosis

June 18, 2018

STF-1019 protects against experimental enterovirus 71 infection

June 18, 2018

Phase I/II study of BioAtla's BA-3021 in advanced solid tumors begins

June 18, 2018

CytomX initiates first-in-human study of CX-2029 in patients with solid tumors or DLBCL

June 18, 2018

hVIVO reports results from phase IIb field study of FLU-v

June 18, 2018

BridgeBio licenses LHON therapy from NeuroVive

June 18, 2018

Teijin Pharma divulges cyclin-dependent kinase CDK4/cyclin D3 and CDK6/cyclin D3 inhibitors

June 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...